Flavio Crippa - Concepedia

Author

Flavio Crippa

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

Crippa, F., F CRIPPA, F Crippa, F G Crippa, F. Crippa, Flavio Crippa, P Russo

223

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Istituti di Ricovero e Cura a Carattere Scientifico

About

Flavio Crippa is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	42	2.7K
2	Health Sciences	17	20	797
3	Engineering	8	8	268
4	Biochemistry	3	3	54
5	Natural Sciences	1	1	31

Flavio Crippa

Publications

Citations

H-Index

Page 1

	Year	Citations
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. Armando Santoro, Gianni Bonadonna, Pinuccia Valagussa, Journal of Clinical Oncology PathologyPharmacotherapyMetronomic ChemotherapyHematological MalignancyRadiation Medicine	1987	380
Imatinib mesylate in chordoma Paolo G. Casali, A. Messina, Silvia Stacchiotti, Cancer	2004	268
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study Laura D. Locati, Paolo Bossi, Federica Perrone, Oral Oncology Malignant DiseaseMedicinePathologyPhase Ii StudyHead And Neck Cancer	2008	212
Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation Flavio Crippa, Ettore Seregni, Roberto Agresti, European Journal of Nuclear Medicine and Molecular Imaging Hormone Receptor StatusBreast OncologyMedicinePathologyPrimary Breast Cancer	1998	185
Response to imatinib plus sirolimus in advanced chordoma Silvia Stacchiotti, Andrea Marrari, Elena Tamborini, Annals of Oncology Gastrointestinal OncologyMedicinePathologyOncologyPlus Sirolimus	2009	169
Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology Claudio Chiesa, Marco Maccauro, Carlo Spreafico, European Journal of Nuclear Medicine and Molecular Imaging Radiation MedicineHepatologyRadiation TherapyMedical ImagingMedicine	2015	159
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. Flavio Crippa, Roberto Agresti, Ettore Seregni, PubMed	1998	151
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial Andrea Necchi, Luigi Mariani, Nadia Zaffaroni, The Lancet Oncology Platinum-resistant Urothelial CancerUrologyGenitourinary CancerMedicinePharmacology	2012	145
Phase II study on lapatinib in advanced EGFR-positive chordoma Silvia Stacchiotti, Elena Tamborini, Salvatore Lo Vullo, Annals of Oncology Tumoral PathologyMedicinePathologyPhase Ii StudyMolecular Oncology	2013	143
Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma Silvia Stacchiotti, Elena Tamborini, Andrea Marrari, Clinical Cancer Research	2009	143

Page 1